Video

Dr. Saba on Unique Set of Challenges Caused By COVID-19 in Head and Neck Cancer

Author(s):

Nabil F. Saba, MD, FACP, discusses how the COVID-19 pandemic has impacted treatment in head and neck cancer and the health care system at large.

Nabil F. Saba, MD, FACP, director of the Head and Neck Medical Oncology Program at Winship Cancer Institute of Emory University, professor in the Department of Hematology and Medical Oncology and Department of Otolaryngology at Emory University School of Medicine, discusses how the COVID-19 pandemic has impacted treatment in head and neck cancer and the health care system at large.

Please visit www.OncLive.com to watch the entitreity of the MJH Life Sciences News Network, which provides the latest news across a variety of healthcare specialties, and a number of interviews with experts in the medical field, many of which are focused on the ongoing COVID-19 pandemic.

Related Videos
Katharine A. Price, MD
Richard Kim, MD
Alexey Danilov, MD, PhD
Alexey Danilov, MD, PhD
Jennifer R. Eads, MD,
David A. Braun, MD, PhD
Kimberly Cannavale, MPH
Pavani Chalasani, MD, MPH
Amma Asare, MD, PhD
Anthony V. D'Amico, MD, PhD